Amgen Inc. (AMGN) Social Stream



Amgen Inc. (AMGN): $243.25

-0.60 (-0.25%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add AMGN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 402

in industry

AMGEN INC (AMGN) Price Targets From Analysts

Use the tables below to see what analysts covering AMGEN INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 18 $298 $185 $242.866 $245.17 -0.94%
2021-11-19 19 $298 $185 $241.937 $245.17 -1.32%
2021-11-22 20 $298 $185 $239.117 $245.17 -2.47%
2021-12-20 21 $298 $185 $237.5 $245.17 -3.13%
2021-12-22 20 $298 $185 $237.888 $245.17 -2.97%
2022-01-04 19 $298 $185 $237.888 $245.17 -2.97%
2022-01-07 19 $298 $185 $235.611 $245.17 -3.9%
2022-01-18 18 $298 $185 $236.764 $245.17 -3.43%
2022-01-28 18 $298 $185 $236.647 $245.17 -3.48%
2022-02-08 18 $298 $194 $239.875 $245.17 -2.16%
2022-03-18 18 $298 $194 $246.125 $245.17 0.39%
2022-04-12 17 $286 $194 $242.8 $245.17 -0.97%
2022-04-26 17 $295 $194 $243.8 $245.17 -0.56%
2022-04-29 15 $295 $194 $247.571 $245.17 0.98%
2022-05-10 15 $295 $208 $248.785 $245.17 1.47%
2022-05-23 16 $295 $208 $249.266 $245.17 1.67%
2022-05-31 16 $295 $208 $249.6 $245.17 1.81%
2022-06-15 16 $295 $208 $249.933 $245.17 1.94%
2022-07-25 16 $295 $208 $252.571 $245.17 3.02%
2022-08-03 16 $295 $208 $250.866 $245.17 2.32%
2022-08-05 17 $295 $208 $250.866 $245.17 2.32%
2022-08-08 17 $295 $208 $252.666 $245.17 3.06%
2022-09-17 18 $295 $182 $248.25 $245.17 1.26%
2022-10-03 18 $295 $182 $250.133 $245.17 2.02%
2022-10-11 18 $295 $182 $251.6 $245.17 2.62%
2022-10-21 18 $295 $182 $251.466 $245.17 2.57%
2022-10-24 18 $295 $182 $254 $245.17 3.6%
2022-11-02 18 $295 $182 $254 $245.17 3.6%
2022-11-03 17 $295 $182 $254 $245.17 3.6%
2022-11-04 17 $300 $182 $256.666 $245.17 4.69%
2022-11-08 18 $300 $182 $257.6 $245.17 5.07%
2022-12-04 13 $325 $182 $259.461 $245.17 5.83%
2022-12-07 13 $325 $182 $260.23 $245.17 6.14%
2022-12-12 12 $325 $182 $261.692 $245.17 6.74%
2022-12-14 12 $325 $182 $262 $245.17 6.86%
2022-12-22 12 $325 $182 $264 $245.17 7.68%
2023-01-19 13 $325 $182 $266.23 $245.17 8.59%
2023-01-27 13 $325 $182 $266.692 $245.17 8.78%
2023-02-01 14 $325 $182 $267.461 $245.17 9.09%
2023-02-02 14 $325 $182 $263.384 $245.17 7.43%

The Trend in the Analyst Price Target


AMGN's average price target has moved up $15.13 over the prior 170 days.

AMGN reports an average of -2.06% for its upside potential over the past 51 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-04-26 17 295 194 243.800 249.87 -2.43%
2022-06-01 16 295 208 249.933 253.42 -1.38%
2022-08-03 16 295 208 250.866 247.14 1.51%
2022-11-03 17 295 182 254.000 265.88 -4.47%
2022-11-08 17 325 182 259.461 292.39 -11.26%

AMGN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.71 4 0 8 2 2 14

The Trend in the Broker Recommendations


AMGN's average broker recommendation rating worsened by 0.15 over the prior 13 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, AMGEN INC's average analyst price target is greater than 4617.07% of them.
  • AMGEN INC's number of analysts covering the stock is higher than 4642.56% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, AMGEN INC's upside potential (average analyst target price relative to current price) is higher than 479.4% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, AMGEN INC's variance in analysts' estimates is lower than -1488.67% of them.

Stocks similar to AMGEN INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are DNA, CGC, and TLRY.

Is AMGN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6276 seconds.